No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
528 |
4. Check minimum number of eventsNone |
528 |
5. Include endpointsNone |
528 |
6. Filter based on genotype QC (FinnGen only) |
528 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q1
- Name in latin
- Aliae malformationes congenitae auris
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of ear
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9613 | 5386 | 4215 |
| Only index persons | 7957 | 4590 | 3367 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.14 | 0.15 | 0.12 |
| Only index persons | 0.15 | 0.17 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 7.65 | 8.54 | 6.47 |
| Only index persons | 9.26 | 10.78 | 7.20 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 528 | 395 | 133 |
| Unadjusted period prevalence (%) | 0.12 | 0.13 | 0.06 |
| Median age at first event (years) | 13.49 | 13.57 | 13.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 471
- Matched controls
- 4711
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
DAD30
NOMESCO Finland
Plastic repair of auricle
7831.7
323.0
321
*
Q17.5
ICD-10 Finland
Prominent ear
+∞
323.0
353
*
Q17.2
ICD-10 Finland
Microtia
+∞
62.9
59
*
DAD10
NOMESCO Finland
Reconstruction of auricle
+∞
33.8
32
*
Q17.3
ICD-10 Finland
Other misshapen ear
+∞
25.2
24
*
Q16.0
ICD-10 Finland
Congenital absence of (ear) auricle
+∞
21.0
20
*
Q16.1
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
+∞
21.0
20
*
Q17.8
ICD-10 Finland
Other specified congenital malformations of ear
+∞
18.9
18
*
Q17.0
ICD-10 Finland
Accessory auricle
+∞
18.9
18
*
ZXA10
NOMESCO Finland
Bilateral
3.2
17.4
103
379
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
18.5
15.3
23
13
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
14.1
172
949
Q17.9
ICD-10 Finland
Congenital malformation of ear, unspecified
+∞
13.6
13
*
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
18.9
13.5
20
11
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
12.8
83
321
ZZG00
NOMESCO Finland
Graft of cartilage
133.4
12.5
13
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
12.1
150
822
7442C
ICD-9 Finland
Congenital anomalies of ear, face and neck, Other specified anomalies of ear[OTAPOSTASIS]
102.0
9.4
10
*
ZXA00
NOMESCO Finland
Right side
2.4
9.0
79
360
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
8.9
8.9
18
21
ZZA00
NOMESCO Finland
Split skin graft
11.9
8.6
15
13
7442B
ICD-9 Finland
Congenital anomalies of ear, face and neck, Other specified anomalies of ear[MICROTIA]
+∞
8.4
8
*
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
+∞
8.4
8
*
4105
FHL
Earlobe reconstruction or plastic
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
7.9
120
700
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
18.7
7.6
11
6
Q18.1
ICD-10 Finland
Preauricular sinus and cyst
+∞
7.3
7
*
DFF00
NOMESCO Finland
Pure tone audiometry
3.1
7.2
38
130
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
30.5
7.2
9
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
20.4
7.2
10
5
4104
FHL
Removable ear repair
40.7
6.8
8
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
12.5
6.6
11
9
Z31.5
ICD-10 Finland
Genetic counselling
2.7
6.4
42
166
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.0
6.4
34
118
Q67.0
ICD-10 Finland
Facial asymmetry
+∞
6.3
6
*
DC1AD
NOMESCO Finland
Temporalbone CT
12.7
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000494) Fungus identified in Specimen by Culture
64
363
1.87
4.80
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
72
447
1.71
4.00
1.6
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
18
68
2.71
3.60
3.3
4.9
umol/l
360.3
391.1
0.40
18
58
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
462
4290
1.62
3.32
9.1
9.2
mg/l
20.2
19.0
0.28
349
3189
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
147
1123
1.43
3.22
1.7
1.6
pmol/l
99.2
96.8
0.32
81
617
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
382
3443
1.40
2.94
3.0
2.8
mmol/l
5.4
5.5
0.27
352
3196
(3024928) Oxygen saturation in Venous blood
13
49
2.69
2.64
1.7
8.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
512
4943
2.18
2.54
13.8
13.7
e12/l
4.6
4.6
0.34
503
4816
(3010813) Leukocytes [#/volume] in Blood
512
4946
2.16
2.48
13.8
13.8
e9/l
6.8
6.8
0.01
502
4816
(3003396) Base excess in Arterial blood by calculation
35
206
1.75
2.40
6.5
10.3
mmol/l
1.3
0.3
1.08
28
151
(3013826) Glucose [Moles/volume] in Serum or Plasma
240
2056
1.31
2.39
4.6
4.6
mmol/l
6.1
6.1
0.04
215
1789
(3007461) Platelets [#/volume] in Blood
511
4938
2.08
2.39
13.8
13.8
e9/l
264.5
262.6
0.30
502
4813
(3011648) Oxygen content in Venous blood
8
23
3.52
2.27
2.0
15.3
%
14.3
12.5
—
8
23
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
369
3363
1.32
2.27
2.6
2.7
mmol/l
1.2
1.1
0.77
348
3186
(3019230) Fractional oxyhemoglobin in Venous blood
11
42
2.65
2.19
1.8
9.1
%
61.7
67.4
0.40
11
42
(3022217) INR in Platelet poor plasma by Coagulation assay
34
205
1.70
2.17
2.9
13.1
inr
1.0
1.2
—
8
47
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
22
117
1.92
2.09
5.6
10.7
%
0.7
0.7
0.12
22
117
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
22
118
1.90
2.04
5.6
10.6
%
1.5
1.4
0.18
22
118
(3032080) INR in Blood by Coagulation assay
118
933
1.34
2.03
4.6
4.6
inr
1.0
1.1
1.29
43
347
(3019060) Gas panel - Arterial blood
20
104
1.96
2.03
4.9
8.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
325
2938
1.28
1.98
3.8
3.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
154
1269
1.30
1.98
5.3
6.8
mmol/l
1.2
1.2
1.22
143
1157
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
184
1562
1.27
1.86
2.4
2.4
nmol/l
72.3
70.5
0.39
173
1462
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
54
0.00
1.86
0.0
1.4
—
37.1
—
0
5
(40761511) CBC panel - Blood by Automated count
477
4564
1.47
1.85
9.3
8.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
56
397
1.46
1.83
1.6
1.6
nmol/l
935.7
1117.4
0.99
40
310
(3005011) Chlamydia sp Ab [Titer] in Serum
5
12
4.20
1.82
1.2
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
414
3877
1.31
1.82
8.9
8.7
mmol/l
139.5
139.4
0.43
400
3743
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
167
1407
1.27
1.79
5.5
7.0
mmol/l
1.2
1.2
1.22
145
1208
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
47
2.37
1.78
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
36
233
1.58
1.78
6.1
6.2
mmol/l
0.8
0.9
0.02
27
165
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
67
2.12
1.77
1.2
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
414
3890
1.30
1.69
8.7
8.7
mmol/l
3.9
3.9
0.07
399
3737
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
42
2.41
1.68
2.1
1.4
promille
2.2
1.4
—
5
35
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
171
0.46
1.61
1.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
273
0.54
1.61
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
63
2.09
1.61
1.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
368
3419
1.25
1.58
4.4
3.9
pmol/l
14.2
14.4
0.55
338
3153
(3014007) Fractional oxyhemoglobin in Arterial blood
20
114
1.78
1.58
6.1
10.9
%
91.2
94.2
0.55
20
114
(3013512) EKG study
84
657
1.33
1.56
2.8
2.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
53
385
1.42
1.55
3.9
3.2
ng/l
511.3
531.5
0.05
45
296
(3044889) 12 lead EKG panel
235
2087
1.23
1.54
2.7
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
56
414
1.39
1.49
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
54
398
1.40
1.46
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
182
1582
1.23
1.44
1.8
1.8
—
—
—
0
0
(4281824)
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
108
885
1.28
1.43
3.3
2.4
ng/l
10.0
18.8
1.17
38
315
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
324
2987
1.22
1.42
3.5
3.6
mmol/mol
36.3
36.6
0.30
305
2841
(3044640) Blood type and Crossmatch panel - Blood
145
1234
1.24
1.40
2.0
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
54
402
1.38
1.39
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
19
112
1.72
1.37
1.7
1.9
ug/l
11.3
5.1
0.27
14
103
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
413
3912
1.26
1.36
5.1
4.5
mu/l
1.8
2.0
0.41
392
3699
(3028707) Methadone [Presence] in Urine by Screen method
37
258
1.47
1.36
2.3
2.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
192
1.54
1.35
5.6
6.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
234
2098
1.21
1.34
2.7
3.0
estimate
0.0
0.0
0.00
37
439
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
37
259
1.46
1.33
5.4
9.6
mmol/l
25.3
24.6
0.89
37
259
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
382
3592
1.23
1.33
3.1
3.0
mmol/l
2.8
2.8
0.08
364
3385
(3020779) Urea [Moles/volume] in Serum or Plasma
36
251
1.47
1.32
3.7
9.1
mmol/l
5.5
6.1
0.54
36
243
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
24
2.52
1.30
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
442
4227
1.28
1.30
4.2
4.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
18
2.79
1.28
1.2
1.6
nmol/l
2.4
2.3
—
5
13
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
44
2.06
1.27
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
44
2.06
1.27
1.3
1.4
—
—
—
0
0
(4198724)
9
44
2.06
1.27
1.8
2.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
44
2.06
1.27
1.3
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
361
0.65
1.27
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
379
3568
1.22
1.27
2.9
2.9
mmol/l
4.6
4.6
0.34
365
3389
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
45
2.02
1.24
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
45
2.02
1.24
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
45
2.02
1.24
1.3
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
138
1185
1.22
1.22
4.1
5.0
g/l
37.9
37.9
0.00
125
1098
(46235355) HIV 1 and 2 tests - Meaningful Use set
236
2135
1.19
1.19
2.3
2.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
22
141
1.58
1.19
1.9
1.7
mmol/l
7.6
7.0
0.51
14
87
(3021960) Folate [Moles/volume] in Serum or Plasma
77
620
1.28
1.19
1.3
1.3
nmol/l
21.5
19.6
0.70
69
546
(44813793)
8
38
2.12
1.19
1.0
1.1
—
—
—
0
0
(4010399)
27
182
1.51
1.18
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
201
1796
1.19
1.16
2.5
2.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
412
3924
1.23
1.16
10.9
11.7
%
13.1
13.2
0.79
403
3841
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
314
2917
1.19
1.16
2.9
2.9
u/l
30.7
29.2
0.32
300
2816
(3021601) Nitrite [Presence] in Urine by Test strip
233
2110
1.19
1.16
3.8
4.2
estimate
0.0
0.0
0.00
40
456
(3009261) Glucose [Presence] in Urine by Test strip
235
2130
1.19
1.15
2.8
3.1
estimate
0.0
0.0
0.00
40
443
(3019225) pH of Specimen
34
242
1.43
1.15
3.0
3.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
5
112
0.44
1.14
1.2
1.3
—
14.4
—
0
9
(3018095) Leukocytes [#/volume] in Urine
155
1356
1.20
1.13
2.7
3.5
e6/l
140.5
49.6
0.61
86
850
(1616796) Gas panel - Central venous blood
11
58
1.92
1.13
1.7
3.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
454
4374
1.27
1.12
9.2
10.3
%
40.6
40.3
0.88
394
3729
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
40
2.02
1.12
1.1
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
449
4322
1.26
1.11
7.2
7.4
u/l
25.8
25.1
0.24
430
4175
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
41
1.97
1.09
1.1
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
27
186
1.48
1.08
1.1
1.1
u/ml
1.0
0.6
0.41
13
102
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
97
1.67
1.08
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
375
3551
1.19
1.06
3.0
2.8
mmol/l
1.4
1.5
1.62
357
3361
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
110
936
1.22
1.06
1.9
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
159
1402
1.19
1.06
1.7
1.8
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
12
67
1.81
1.05
1.7
5.0
mmol/l
1.4
1.6
0.25
12
67
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
98
1.65
1.04
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
111
948
1.22
1.03
1.9
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
233
2127
1.17
1.02
4.8
6.1
%
31.4
31.6
0.06
214
2025
(3018010) Neutrophils/100 leukocytes in Blood
230
2098
1.17
1.02
4.6
6.0
%
53.8
54.5
0.45
213
1991
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
189
1.45
1.01
1.1
1.1
u/ml
2.5
6.1
1.65
18
127
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
99
1.64
1.01
10.5
15.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
93
782
1.23
1.01
2.6
2.8
ug/g
68.1
88.1
0.76
79
604
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
132
0.52
1.00
1.4
2.6
—
—
—
0
0
(3012544) pH of Venous blood
41
311
1.35
0.98
2.2
7.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
23
2.18
0.98
2.2
2.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
3.6
—
23.3
—
0
30
(3013115) Eosinophils [#/volume] in Blood
236
2163
1.16
0.97
5.1
6.6
e9/l
0.2
0.2
1.90
210
1926
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
134
1173
1.19
0.96
2.3
3.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
34
252
1.37
0.94
1.1
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
280
2604
1.16
0.94
5.4
5.7
u/l
76.6
77.5
0.13
259
2442
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
135
1185
1.19
0.94
2.0
2.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
37
1.90
0.94
1.0
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
179
1610
1.17
0.93
2.7
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
219
2001
1.16
0.93
4.0
4.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
258
2387
1.16
0.93
6.0
8.4
e9/l
4.1
3.8
0.86
228
2071
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
67
549
1.25
0.92
1.6
1.5
pmol/l
461.7
27755529.2
0.80
62
490
(3020891) Body temperature
13
78
1.68
0.92
2.5
5.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
129
1131
1.19
0.91
2.9
3.2
estimate
0.0
0.0
0.80
38
445
(3000991) Gas panel - Venous blood
36
272
1.35
0.90
4.8
9.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
29
2.08
0.89
1.5
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
368
3502
1.17
0.89
6.7
7.0
ml/min/173m2
101.6
101.9
0.07
275
2667
(3021447) Carbon dioxide [Partial pressure] in Venous blood
40
308
1.32
0.88
2.2
7.4
kpa
5.9
5.8
0.26
40
299
(3013707) Erythrocyte sedimentation rate by Westergren method
299
2803
1.15
0.88
3.2
3.5
mm/h
7.3
8.0
0.76
284
2597
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
29
212
1.39
0.88
1.1
1.2
u/ml
2.2
2.2
0.01
17
101
(3024354) Oxygen [Partial pressure] in Venous blood
36
273
1.34
0.88
2.1
7.7
kpa
4.8
4.9
0.17
36
266
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
181
1638
1.16
0.87
2.4
2.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
107
929
1.19
0.85
2.9
3.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
260
0.68
0.83
1.7
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
26
189
1.40
0.82
1.1
1.1
u/ml
1.7
3.1
—
6
51
(3001122) Ferritin [Mass/volume] in Serum or Plasma
264
2462
1.14
0.82
2.8
2.9
ug/l
62.4
62.0
0.02
250
2317
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
212
0.65
0.81
1.2
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
41
322
1.30
0.80
1.4
1.6
iu/l
19.7
14.2
0.52
31
252
(3013290) Carbon dioxide [Partial pressure] in Blood
11
66
1.68
0.79
1.7
2.5
kpa
5.1
4.8
0.64
11
66
(3027315) Oxygen [Partial pressure] in Blood
11
66
1.68
0.79
1.7
2.5
kpa
9.3
9.5
0.16
11
66
(3026008) Bacteria identified in Urine by Culture
128
1136
1.17
0.79
2.2
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
77
655
1.21
0.77
3.1
3.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
34
1.77
0.76
2.5
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
461
1.24
0.76
2.0
2.6
ng/l
4933.0
397.4
0.52
24
194
(1761868) Lipid panel - Serum or Plasma
159
1438
1.15
0.76
1.9
1.9
—
—
—
0
0
(4062490)
9
53
1.71
0.75
1.6
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
254
1.32
0.75
1.1
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
217
2007
1.14
0.75
5.1
6.5
%
7.8
7.9
0.18
198
1901
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
64
536
1.22
0.75
2.0
2.9
e6/l
5.0
4.1
0.22
32
292
(4211845)
5
24
2.09
0.74
2.2
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
65
547
1.21
0.73
1.8
2.7
e6/l
1.1
0.7
0.62
30
299
(3015377) Calcium [Moles/volume] in Serum or Plasma
110
972
1.17
0.72
2.7
2.5
mmol/l
2.4
2.4
0.21
93
876
(3022145) Colonoscopy Study observation
41
328
1.27
0.71
1.6
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
7
40
1.76
0.71
2.0
1.6
mmol/l
5.1
5.1
—
7
40
(3019198) Lymphocytes [#/volume] in Blood
237
2210
1.13
0.71
5.1
6.1
e9/l
2.0
2.0
0.16
214
1981
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
195
1.35
0.71
1.3
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
41
1.72
0.70
1.4
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
113
1003
1.16
0.70
3.8
7.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
1.6
1.3
—
—
—
0
0
(4094501)
7
43
1.64
0.67
1.3
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
377
1.24
0.67
1.2
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
223
2080
1.12
0.66
5.2
6.2
e9/l
0.5
0.5
0.50
197
1827
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
83
723
1.18
0.65
2.0
1.6
%
1.4
1.3
0.77
74
669
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
44
360
1.24
0.65
1.4
1.4
miu/ml
166.7
283.9
1.49
22
183
(3022096) Basophils/100 leukocytes in Blood
206
1914
1.13
0.65
5.0
6.4
%
0.7
0.6
0.25
187
1799
(3006504) Eosinophils/100 leukocytes in Blood
214
1994
1.12
0.64
5.0
6.3
%
3.0
2.8
1.07
194
1870
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
38
307
1.26
0.63
2.4
7.5
mmol/l
1.8
1.2
0.62
30
235
(3018677) aPTT in Platelet poor plasma by Coagulation assay
50
417
1.22
0.63
4.0
3.4
s
30.9
29.5
0.84
50
406
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.8
5.6
ug/l
2.4
2.2
—
5
30
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
58
493
1.20
0.60
1.2
1.3
iu/ml
196.6
160.8
0.20
27
184
(3006315) Basophils [#/volume] in Blood
223
2089
1.12
0.60
5.2
6.2
e9/l
0.0
0.0
0.35
198
1834
(3029075) Extractable nuclear Ab panel - Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
27
210
1.30
0.60
3.3
3.3
%
21.1
22.7
0.28
14
71
(42870588) Differential panel, method unspecified - Blood
148
1354
1.13
0.60
5.0
6.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
40
483
0.81
0.58
1.7
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3015736) pH of Urine
177
1640
1.12
0.58
2.8
2.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
56
477
1.19
0.58
2.3
2.2
umol/l
14.1
15.2
0.54
50
440
(3004809) Band form neutrophils/100 leukocytes in Blood
6
38
1.59
0.54
1.5
3.4
%
1.5
1.5
—
6
30
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
125
1.37
0.54
1.9
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
134
1.36
0.53
1.8
2.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
14
100
1.41
0.52
8.4
10.6
mmol/l
24.3
23.5
0.84
14
91
(3004789) Transferrin [Mass/volume] in Serum or Plasma
50
427
1.19
0.51
2.3
2.2
g/l
2.5
2.5
0.15
43
395
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
41
1.47
0.50
1.5
5.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
94
847
1.13
0.49
2.0
2.2
mg/l
1.3
1.0
0.30
68
581
(3004616) Nuclear Ab [Presence] in Serum
7
45
1.56
0.49
1.3
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
51
439
1.18
0.48
1.7
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
104
944
1.13
0.48
3.1
3.0
kg/l
1.0
1.0
—
9
136
(3010421) pH of Blood
11
76
1.46
0.48
1.8
2.4
ph
7.4
7.4
0.76
11
66
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
143
0.69
0.48
2.1
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
137
1265
1.11
0.48
2.3
2.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
47
1.50
0.47
1.0
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.47
1.0
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.47
1.3
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
31
255
1.23
0.47
1.8
3.5
g/l
0.2
0.2
0.07
31
242
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
108
986
1.12
0.46
2.8
2.3
u/l
48.7
54.3
1.60
103
907
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
82
0.61
0.46
3.4
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
165
1.28
0.45
1.2
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
86
1.40
0.45
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
121
1.33
0.44
2.0
2.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
13
95
1.38
0.44
1.3
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
33
276
1.21
0.43
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
78
1.42
0.43
1.4
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
191
1804
1.09
0.42
1.8
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
128
1186
1.10
0.42
1.5
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
32
1.57
0.42
1.0
2.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
57
1.41
0.42
1.0
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
70
1.44
0.42
1.4
2.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
44
380
1.17
0.41
2.5
2.3
%
23.0
25.2
0.45
39
336
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
(4146454)
0
15
0.00
0.41
0.0
3.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
10
138
0.72
0.41
5.4
14.9
mg/l
1.1
1.1
—
10
132
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
123
1.31
0.41
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
72
647
1.13
0.40
2.1
2.8
umol/l
322.1
4039.1
2.06
63
592
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
18
0.00
0.40
0.0
4.6
—
—
—
0
0
(3024471) HLA-A [Type]
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
101
928
1.11
0.39
1.9
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
178
1.25
0.39
1.1
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.1
miu/ml
1812.0
1599.2
—
5
35
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
148
0.74
0.39
1.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
137
1280
1.09
0.38
1.5
1.4
g/l
1.8
2.0
1.19
87
776
(3009214) Lutropin [Units/volume] in Serum or Plasma
32
271
1.19
0.38
1.6
1.6
u/l
10.1
8.5
0.27
25
213
(3011288) Drugs identified in Urine by Screen method
47
412
1.15
0.38
2.6
2.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
290
1.18
0.38
4.3
4.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
134
1.28
0.37
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
162
1.24
0.36
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
90
1.34
0.36
1.2
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
79
0.63
0.35
1.0
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
9
123
0.73
0.35
1.2
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
71
644
1.12
0.35
2.3
2.4
u/l
11733.4
5572.4
0.62
30
269
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
43
1.40
0.35
1.0
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
64
578
1.12
0.34
1.4
1.4
titre
706.7
438.9
—
6
108
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
169
1602
1.08
0.34
4.2
5.2
umol/l
11.4
10.1
0.64
154
1500
(3052851) Hemolysis interference index of Serum or Plasma
6
88
0.68
0.33
2.3
3.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
23
273
0.84
0.32
3.4
4.4
u/l
252.0
224.0
0.42
23
264
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
83
1.33
0.32
1.3
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
52
1.35
0.31
1.7
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
18
147
1.23
0.31
1.1
1.1
u/ml
10.7
6.2
—
7
67
(3001019) Free T4 and TSH panel - Serum or Plasma
38
334
1.15
0.31
1.6
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
138
1.24
0.31
1.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
93
1.30
0.30
2.3
2.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
16
130
1.24
0.29
1.1
1.1
u/ml
3.5
6.9
—
6
62
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
117
0.77
0.27
1.0
1.1
—
8.6
—
0
8
(3025159) Blasts/100 leukocytes in Blood
21
247
0.84
0.27
9.2
4.8
%
0.0
0.2
—
10
50
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
131
1.23
0.27
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
60
549
1.10
0.27
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
179
1715
1.07
0.27
1.9
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
71
656
1.10
0.27
1.3
1.2
u/ml
3.1
7.5
1.02
31
261
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
141
1.21
0.26
2.2
1.9
iu/l
4.1
5.3
—
5
52
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
86
1.29
0.26
1.3
6.5
—
727.2
—
0
9
(36304419) Bacteria [Presence] in Urine
103
969
1.08
0.26
2.0
3.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
142
1.20
0.25
1.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
82
0.73
0.24
5.2
4.0
e9/l
5.3
3.8
—
6
82
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
83
0.72
0.24
5.3
4.0
%
55.2
55.3
—
6
83
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
85
0.70
0.24
1.0
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
27
238
1.14
0.22
1.3
1.7
mg/l
2.8
3.6
0.29
19
151
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
11
135
0.81
0.22
1.5
1.9
u/l
40.5
39.9
0.02
11
125
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
199
0.85
0.22
2.3
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
101
957
1.07
0.21
2.0
3.0
e6/l
1.0
0.2
0.66
66
696
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
11
0.00
0.21
0.0
7.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
20.3
—
0.4
—
0
10
(3013336) Amino acids [Identifier] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
101
0.79
0.21
1.4
1.8
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
79.3
—
0
7
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
7.4
—
0
7
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
12
0.00
0.21
0.0
5.9
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.9
—
35.6
—
0
12
(3000850) Epithelial cells [#/volume] in Urine
77
723
1.08
0.21
1.8
2.5
e6/l
35.1
10.5
0.43
57
619
(36660697) Celiac disease serology panel - Serum
56
519
1.09
0.21
1.2
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
3.7
—
205.6
—
0
13
(3003327) Ova and parasites identified in Stool by Light microscopy
25
221
1.14
0.20
1.4
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
99
940
1.07
0.20
3.0
3.4
mmol/l
8.0
8.7
0.75
88
829
(3042733) HLA Ab [Presence] in Serum
0
14
0.00
0.20
0.0
3.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
149
1433
1.06
0.20
1.4
1.4
u/ml
2.9
1.9
0.24
41
357
(44790048)
6
49
1.23
0.20
1.5
1.6
—
—
—
0
0
(44806118)
6
49
1.23
0.20
1.5
1.6
—
—
—
0
0
(44790049)
6
49
1.23
0.20
1.5
1.6
—
—
—
0
0
(44790047)
6
49
1.23
0.20
1.5
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
260
0.88
0.20
2.0
2.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
96
1010
0.94
0.20
1.5
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
50
1.20
0.19
1.2
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
24
270
0.88
0.19
2.1
1.8
g/l
0.9
1.2
1.20
24
253
(3002179) Metamyelocytes/100 leukocytes in Blood
22
249
0.88
0.19
7.0
4.3
%
0.0
0.4
—
9
45
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
165
1.16
0.19
1.1
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
52
1.16
0.19
1.3
1.7
titre
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
137
1.17
0.19
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
16
137
1.17
0.19
1.1
4.3
ug/l
55.3
4.7
0.44
11
99
(3002523) Influenza virus A Ag [Presence] in Specimen
16
137
1.17
0.19
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
59
1.19
0.18
1.1
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
99
1036
0.95
0.17
4.4
3.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
25
278
0.89
0.17
3.3
5.9
%
2.0
1.6
0.37
20
260
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
63
1.11
0.17
1.1
2.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
134
1292
1.05
0.17
2.8
3.0
u/l
30.5
27.6
0.49
124
1227
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
5
69
0.72
0.17
2.8
1.9
ug/l
0.7
5.2
—
5
59
(3017181) Myelocytes/100 leukocytes in Blood
24
267
0.89
0.17
8.2
4.6
%
0.4
0.8
0.94
11
65
(3002582) Erythrocytes [#/volume] in Urine
111
1065
1.05
0.17
2.2
3.1
e6/l
23.3
130.7
0.93
72
793
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
20
177
1.14
0.16
1.5
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
38
411
0.92
0.16
1.9
3.5
umol/l
6.3
7.0
0.15
32
330
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
55
517
1.07
0.15
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
119
0.84
0.15
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
79
1.14
0.15
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
83
1.09
0.14
1.3
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
286
1.09
0.13
1.5
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
11
94
1.17
0.13
2.5
4.0
mmol/l
26.0
24.5
0.82
11
89
(3026782) Osmolality of Urine
71
679
1.05
0.12
2.1
2.6
mosm/kgh2o
554.0
584.8
0.41
55
579
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
239
1.09
0.12
1.5
1.4
—
—
—
0
0
(4034850)
13
114
1.14
0.12
2.2
7.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
57
543
1.06
0.11
3.3
3.6
mg/l
66.4
81.1
0.20
41
385
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
70
671
1.05
0.11
1.3
1.2
iu/ml
23.9
16.9
0.44
12
186
(3047352) Trisomy 18 risk [Likelihood] in Fetus
38
404
0.94
0.11
1.5
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
279
1.08
0.11
2.4
2.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
291
0.92
0.11
2.0
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
189
1928
0.97
0.11
7.2
8.2
e9/l
0.0
0.0
0.78
147
1549
(3034274) Bile acid [Moles/volume] in Serum --fasting
25
231
1.09
0.11
1.9
2.7
umol/l
3.7
4.8
0.81
19
180
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
202
1.09
0.10
2.5
1.9
u/ml
71.4
44.4
0.21
22
190
(21494755) Public health laboratory ask at order entry panel
69
663
1.05
0.10
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
39
368
1.06
0.10
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
58
555
1.05
0.10
2.1
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
59
565
1.05
0.10
3.9
4.4
mg/mmol
13.8
40.4
0.44
42
397
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
20
183
1.10
0.10
4.5
6.0
ng/l
59.8
63.8
0.16
20
168
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
104
1010
1.04
0.10
2.1
2.3
mg/l
2.3
2.5
0.63
87
872
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
44
1.14
0.10
13.8
18.5
nmol/l
897.6
1547.2
—
5
44
(3049717) Cytology report of Urine Cyto stain
5
44
1.14
0.10
2.0
1.6
—
—
—
0
0
(4027681)
5
46
1.09
0.09
1.2
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
46
1.09
0.09
3.4
3.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
46
1.09
0.09
1.6
2.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
39
411
0.94
0.09
1.5
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
106
1032
1.03
0.09
1.5
1.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
(4035726)
22
204
1.08
0.09
1.1
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
45
430
1.05
0.08
2.0
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
52
499
1.05
0.08
1.4
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
283
1.06
0.08
1.5
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
67
1.05
0.08
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
67
1.05
0.08
1.4
1.3
—
—
—
0
0
(4306422)
7
68
1.03
0.08
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
34
323
1.06
0.07
3.2
2.6
%
33.2
32.7
0.09
25
234
(3045424) Erythrocytes [Presence] in Urine
6
73
0.82
0.07
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
422
1.05
0.07
1.3
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
44
422
1.05
0.07
2.8
2.3
mmol/l
2.4
2.4
0.15
34
357
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
81
0.86
0.07
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
24
255
0.94
0.07
8.2
4.7
%
0.1
0.1
0.11
11
58
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
95
0.84
0.06
2.4
2.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
132
0.91
0.06
2.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
58
562
1.04
0.06
1.5
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
103
0.87
0.06
1.3
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
48
465
1.04
0.05
2.1
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
62
636
0.97
0.05
2.2
2.1
—
—
—
0
0
(1002224) Polysomnography panel
15
161
0.93
0.05
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
79
807
0.98
0.05
1.5
1.6
mmol/l
1.4
1.3
1.02
71
726
(3045414) Leukocytes [Presence] in Urine
18
191
0.94
0.04
1.3
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
31
298
1.04
0.04
1.8
2.1
e9/l
4.5
4.2
0.25
24
265
(3027008) Opiates [Presence] in Urine
61
596
1.03
0.04
2.1
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
39
402
0.97
0.04
1.4
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
44
451
0.97
0.03
2.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
92
1.09
0.03
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
58
591
0.98
0.03
2.1
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
61
599
1.02
0.03
2.2
2.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
16
152
1.05
0.02
5.7
4.8
g/l
3.3
3.3
0.10
16
145
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
178
0.95
0.02
1.6
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
40
409
0.98
0.02
2.5
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
22
212
1.04
0.02
3.9
2.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
11
117
0.94
0.01
1.5
1.3
pmol/l
39.4
52.8
1.49
11
111
(3037121) Protein [Mass/volume] in Urine
14
133
1.05
0.01
2.8
5.1
g/l
0.2
0.4
—
5
73
(3000764) Benzodiazepines [Presence] in Urine
60
593
1.01
0.01
2.1
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
136
0.95
0.00
1.2
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
206
0.97
0.00
1.7
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
14
135
1.04
0.00
1.2
1.8
—
4.5
—
0
5
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
204
0.98
0.00
2.3
2.3
ml/min/173m2
98.3
88.9
—
6
72
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
12
123
0.98
0.00
1.8
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
123
0.98
0.00
2.0
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
51
505
1.01
0.00
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
51
506
1.01
0.00
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
65
646
1.01
0.00
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
50
503
0.99
0.00
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
51
507
1.01
0.00
1.4
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
39
392
0.99
0.00
1.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
41
412
0.99
0.00
1.5
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
131
0.99
0.00
1.1
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
79
792
1.00
0.00
3.0
3.2
ph
7.4
7.4
0.30
15
135
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
176
1759
1.00
0.00
1.7
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
63
0.95
0.00
1.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
87
0.92
0.00
2.0
1.7
%
13.3
13.0
—
8
87
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
7.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
150
1.00
0.00
2.2
2.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
29.6
—
0
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
73
0.96
0.00
1.1
7.2
—
3284.5
—
0
8
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
71
0.99
0.00
1.0
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.8
—
118.9
—
0
6
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
71
0.99
0.00
1.4
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
56
0.89
0.00
1.2
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4268621)
6
65
0.92
0.00
2.3
2.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
79
1.01
0.00
1.1
1.1
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
21.8
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_EAR and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_EAR.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_EAR – Other congenital malformations of ear
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data